Prevention and Treatment of Oral Candidiasis Among Pediatric HIV Patients

Treatment of Oral Candidiasis by chlorhexidine gluconate oral rinse. a clinical study Among Pediatric HIV Patients.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2011/12/002212

Enrollment

Registered

2011-12-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- HIV positive pediatric patients

Interventions

Intervention1: Chlorhexidine gluconate: 5 ml mouth rinse,0.12%, twice daily for three months. periogaurd 0.12% Control Intervention1: Chlorhexidine gluconate: 5 ml mouth rinse,0.12%, once daily for t

Eligibility

Inclusion criteria

Inclusion criteria: 1.HIV positive pediatric patients. 2.CFU greater than 5. 3.Not on any systemic medication since one month. 4.Only pseudo membranous or erythematous candidiasis

Exclusion criteria

Exclusion criteria: 1.On systemic medication. 2.CFU less than 5. 3.Any other type of candidiasis.

Design outcomes

Primary

Measure	Time frame
prevention and treatment of oral candidiasis among pediatric HIV positive patients using chlorhexidine gluconate-a clinical studyTimepoint: 3 months	—

Secondary

Measure	Time frame
micro-biologic analysis of Candidal speciesTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Karthik Hegde

Mahatma Gandhi Dental College and Hospital, jaipur

gopakr_nair@yahoo.com09845081625

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026